CONSOLIDATED INTERIM REPORT FOR IV QUARTER AND 12 MONTHS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CONSOLIDATED INTERIM REPORT FOR IV QUARTER AND 12 MONTHS OF 2014 (UNAUDITED)

Tallinn, 2015-02-20 17:55 CET (GLOBE NEWSWIRE) -- Total revenue for twelve months of 2014 was 10,3 mln EUR, a decrease of 16% compared to the reference period. Net operating result during twelve months increased by 27,6 mln EUR (1 626%) compared to the reference period, totalling to profit of 25,9 mln EUR (2013 12 months: -1,7 mln EUR). Net operating profit for the fourth quarter of 2014 was 27,6 mln EUR (2013 Q4: net operating loss of 0,8 mln EUR). Net operating result was influenced by reclassification of assets and recording them in fair value (more details in Note 6). Net result for the twelve months of 2014 has increased by 24,9 mln EUR (968%) compared to the reference period, totalling to profit 22,4 mln EUR (2013 12 months: -2,6 mln EUR). Net result for the fourth quarter of 2014 was profit 25,3 mln EUR (2013 Q4: net result -0,7 mln EUR).

Consolidated financial   report        

Consolidated interim statements of financial position      

(Th. EUR)                                            Notes          31.12.2014    31.12.2013 ________________________________________________________________              ASSETS            Current Assets                Cash and cash equivalents                                          1 881            2 759     Current receivables                                                      2 463            2 738     Inventories                                              6                  14 535           45 587                                                                 _______________________________ Total Current Assets                                                    18 879          51 084                 Non-Current Assets                Non-current receivables                                                  150               168     Deferred tax assets                                                             0               540     Property, plant and equipment               5                   17 619          20 221     Investment property                               6                   88 110          26 001     Intangible assets                                                              273              280                                                                 ______________________________ Total Non-Current Assets                                         106 152          47 210             TOTAL ASSETS                                                           125 031         98 294

(Th. EUR)                                               Notes        31.12.2014    31.12.2013 _______________________________________________________________

LIABILITIES AND EQUITY            Current Liabilities                Current debt                                            7                   16 348          11 730     Customer advances                                                      1 548               501     Current payables                                                           4 761            2 133     Taxes payable                                                                   177               189     Short-term provisions                                                           5                 47                                                                 ______________________________ Total Current Liabilities                                                22 839         14 600                 Non-Current Liabilities                Long-term debt                                       7                   13 430          17 040     Other long-term liabilities                                                   79                 54     Deferred income tax liability                                          2 744            1 758     Long-term provisions                                                       151               147                                                                  _____________________________ Total Non-Current Liabilities                                       16 404          18 999             TOTAL LIABILITIES                                                       39 243          33 599  

Equity attributable to equity holders of the parent                        Share capital in nominal value                                         10 821         10 821 Paid in capital                                                                     1 474          1 474 Statutory reserve                                                                1 064          1 064 Revaluation reserve                                                            9 389        11 330 Foreign currency differences                                               -143         -1 277 Retained earnings                                                            39 778        42 378 Profit (loss) for the period                                                 21 381        -2 600                                                                   ______________________________ Total equity attributable to equity holders of the parent                                         83 764        63 190 Non-controlling interest                                                  2 024          1 505 TOTAL EQUITY                                                               85 788        64 695             TOTAL LIABILITIES AND EQUITY                              125 031        98 294  

Consolidated interim statements of comprehensive income

(Th. EUR)                                Notes    2014 12M    2013 12M     2014 Q4    2013 Q4 _____________________________________________________________________                                Operating income                    Revenue                                    3, 8           10 335         12 287           2 174        3 040 Cost of goods sold                        9            -7 756         -9 199          -1 934       -2 357                                               ______________________________________________ Gross profit                                                2 579           3 088              240           683                     Marketing expenses                                      -530             -420             -155          -129 Administrative expenses            10            -5 160          -4 606          -1 179       -1 285 Other income                               6            31 659             410          31 302           255 Other expenses                           6             -2 689            -384          -2 629          -310                                               _____________________________________________ Operating profit (loss)                            25 859         -1 912          27 579          -786

Financial income                        11                   45             447                   2             18 Financial expense                      11             -1 627          -1413              -419            -66                                               ______________________________________________ Profit (loss) before income tax                                                24 277         -2 878           27 162         -834 Income tax                                                  -1 908               84            -1 887            88                                               ______________________________________________ Net profit (loss) for the period              22 369         -2 794            25 275        -746                         Foreign exchange differences                  -1 134*              -64            -1 134*         -28                         Equity holders of the parent                21 381          -2 880            24 151        -772 Non-controlling interest                           -146                22                  -10            -2                                                 Earnings per share (EUR)          12             0,41            -0,05                0,47       -0,01 Diluted earnings per share (EUR)                         12             0,41            -0,05                0,47       -0,01  

*Due to Latvia entering into Eurozone on 01.01.2014, the Company has considered currency exchange differences realised and accordingly written off currency exchange differences in amount 1 134 th euros.

Consolidated interim statements of cash flows

Th. EUR                                      Note    2014 12M    2013 12M    2014 Q4    2013 Q4 ______________________________________________________________________

Cash flows from operating activities                     Profit (loss) for the year                               22 369           -2 578       25 275         -530 Adjustments for:                          Depreciation and amortisation      of non-current assets                 5               749               794            222           261      Change in fair value of      investment property                    6        -31 696                  85     -32 256          -253      Gain/loss from sale of PPE                           -7                   -4             -4              -4      Loss from impairment of PPE    5           1 946                    0        1 946               0      Gain/loss from disposal      of subsidiary                               4               -19                    0               0               0      Finance income and      costs, net                                  11           1 518             1 329           397             34      Net foreign exchange gain / loss                    0                  64               0               0      Other non-monetary      changes (net amounts)                       -29 924               -914     -30 571          -141 Movements in working capital:                          Change in trade receivables      and prepayments                                       275                460           770            337      Change in inventories                           31 052             2 604       32 233           695      Change in liabilities and      prepayments                                           3 664               -126        1 314            518      Change in provisions                                  -38            -1 972               4           -503  ______________________________________________________________________ Net cash generated by operating activities                                      -111               -258          -670            442 ______________________________________________________________________

Cash flows from investing activities                    Payments for property, plant and equipment                        5            - 171               -47            -92             -14 Proceeds from disposal of property, plant and equipment                           11                 10               4                6 Payments for investment property   6            -822              -302          -262              36 Proceeds from disposal of investment property                                            0                318               0             318 Proceeds from disposal of subsidiaries                                      4             146                   0               4                 0 Interest received                                                61                 17             55                 6 ______________________________________________________________________ Net cash (used in) / generated by investing activities                                -775                  -4           -291             352 ______________________________________________________________________

Cash flows from financing activities                    Proceeds- increase of share capital                  0               184                 0                0 Proceeds- increase of paid- in capital               0             1 474                 0                0 Net proceeds from bonds                              547             1 640                 0         1 000 Proceeds from borrowings                         3 448             2 930           1 608           500 Repayment of borrowings                         -2 840            -2 757             -575          -995 Interest paid                                               -1 147            -1 157               -85            -26 _____________________________________________________________________ Net cash used in financing activities           8             2 314               948           479 _____________________________________________________________________                          Net change in cash and cash equivalents                                       -878              2 052               -13        1 273                     Cash and cash equivalents at the beginning of the period                     2 759                707             1 894       1 486 Cash and cash equivalents at the end of the period                               1 881            2 759              1 881      2 759 _____________________________________________________________________  

         Iveta Vanaga          Head of Investor Relations          Phone: +37129239064          E-mail: iveta@prokapital.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 305

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 36

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

X-Bow Systems Appoints Experienced COO to Boost Growth

Updated Category News Views 202

X-Bow Systems Inc. scored a major win back in early 2024, tapping Mike Bender as the new Chief Operating Officer. Now, you gotta know—this guy's got over thirty years under his belt in aerospace and defense, so he's not just some suit walking in off the street. New COO in Charge: What’s His Game Plan? Bender's gonna oversee the company's factories and supply chain...

Continue Reading
UroGen Pharma Q3 Financial Overview: Anticipating UGN-102 Launch

Updated Category News Views 108

UroGen Pharma's Third Quarter Financial Report UroGen Pharma Ltd. (NASDAQ: URGN), a company focused on developing innovative therapies for urothelial and specialty cancers, has recently published their financial outcomes for the third quarter of 2024, along with key updates on their operations. This report is particularly pivotal, as it sets the stage for UroGen's future...

Continue Reading
Understanding Recent Options Trends for Chevron: Key Insights

Updated Category News Views 87

Decoding Chevron's Recent Options Activity Investors are closely watching Chevron as recent options activity reveals significant trends among traders. An analysis of the latest trades indicates a predominantly bearish sentiment, with a total of 16 unusual trades being noted. This movement offers a compelling glimpse into investor expectations and potential future price...

Continue Reading
New Research Highlights Life-Extending Benefits of Quitting Smoking for Cancer Patients

Updated Category News Views 160

Research Highlights Impact of Quitting Smoking on Cancer Survival Recent studies indicate that individuals diagnosed with stage III or IV cancer who stop smoking can enjoy nearly one additional year of life compared to those who continue the habit. This finding underscores the essential role that smoking cessation support plays in cancer care. Significant Findings from...

Continue Reading
De La Rue plc Strategic Dealings Unfolding in the Market

Updated Category News Views 189

Overview of Dealings in De La Rue plc As the market evolves, companies like De La Rue plc are continuously involved in dynamic trading activities that provide essential insights into their operations. These dealings are not only a reflection of market conditions but also signify a company’s strategy to navigate the complexities of financial frameworks. Key Details of...

Continue Reading